2019
DOI: 10.1080/03639045.2019.1652637
|View full text |Cite
|
Sign up to set email alerts
|

Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…Currently, most of the drug products available do not address the growing demand for personalized therapies. Many of them face several formulation challenges due to the physicochemical properties of the APIs, which may prevent the development of a suitable pharmaceutical form that exerts an adequate therapeutic effect [133][134][135]. However, the rapid growth of nanotechnology intends to contribute greatly to medical and pharmaceutical sciences, providing innovative treatments that can improve patients' lives.…”
Section: Technological Issues For the Formulation Of Poorly Water-solmentioning
confidence: 99%
“…Currently, most of the drug products available do not address the growing demand for personalized therapies. Many of them face several formulation challenges due to the physicochemical properties of the APIs, which may prevent the development of a suitable pharmaceutical form that exerts an adequate therapeutic effect [133][134][135]. However, the rapid growth of nanotechnology intends to contribute greatly to medical and pharmaceutical sciences, providing innovative treatments that can improve patients' lives.…”
Section: Technological Issues For the Formulation Of Poorly Water-solmentioning
confidence: 99%
“…As the results obtained through the analysis of natural raw materials are influenced in some degree by noise or uncontrolled variables, there must be a strategy for the minimization of the effects caused by them. That's why randomization was employed in this study, because it allows a better statistical distribution of the error attributable to those factors among the results (Castillo-Henríquez et al, 2019a;Mead et al, 2012;Reichert et al, 2019).…”
Section: Output Variablementioning
confidence: 99%
“…[21] Remarkably, since QbD was accepted and strongly advised by the FDA in 2004, DoE has been widely reported in the literature for screening and optimization applications, from clas-sical dosage forms to nano-enabled medicinal products, to provide a comprehensive understanding of pharmaceutical formulations and their manufacturing process. [20][21][22][23] Various CQAs of NCs prepared by the solvent-antisolvent nanoprecipitation (e.g., size, polydispersity, morphology, stability) are impacted by the materials and the unit operations. Hence, several factors must be optimized during early development.…”
Section: Introductionmentioning
confidence: 99%
“…[ 21 ] Remarkably, since QbD was accepted and strongly advised by the FDA in 2004, DoE has been widely reported in the literature for screening and optimization applications, from classical dosage forms to nano‐enabled medicinal products, to provide a comprehensive understanding of pharmaceutical formulations and their manufacturing process. [ 20–23 ]…”
Section: Introductionmentioning
confidence: 99%